Infectious Disease · ICD-10: B55.0

Visceral Leishmaniasis

INDICATIONS AND USAGE Amphotericin B liposome for injection is indicated for the following: Empirical therapy for presumed fungal infection in febrile, neutrope…

Medically reviewed by MedCentralHub Medical Review Board, Licensed Pharmacists & Physicians · May 2026

Check Interactions Browse Medicines

ICD-10 B55.0

Visceral LeishmaniasisInfectious Disease

Section 01

Overview

INDICATIONS AND USAGE Amphotericin B liposome for injection is indicated for the following: Empirical therapy for presumed fungal infection in febrile, neutropenic patients. Treatment of Cryptococcal Meningitis in HIV-infected patients (see DESCRIPTION OF CLINICAL STUDIES) . Treatment of patients with Aspergillus species, Candida species and/or Cryptococcus species infections (see above for the treatment of Cryptococcal Meningitis) refractory to amphotericin B deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate. Treatment of visceral leishmaniasis. In immunocompromised patients with visceral leishmaniasis treated with amphotericin B liposome for injection, relapse rates were high following initial clearance of parasi...

Key Clinical Points

•Diagnosis typically involves a clinical evaluation, relevant blood tests, and imaging or specialist assessment as indicated by your symptoms and risk profile.
•Risk factors for Visceral Leishmaniasis include age, family history, lifestyle factors, and underlying health conditions. Identifying your personal risk can help with early prevention.
•Lifestyle modifications — including regular physical activity, a balanced diet, and weight management — are often a core part of treatment and can help prevent or delay complications.
•There are different types of Visceral Leishmaniasis with varying causes, symptoms, and treatment pathways. Your healthcare provider will determine which type applies to you.
•Early recognition of symptoms and prompt medical evaluation significantly improve outcomes. Do not delay seeking care if you notice warning signs.

This information is for educational purposes only. Always consult a qualified healthcare professional for diagnosis and personalized treatment.

Section 02

Signs & Symptoms

Section 03

Causes & Pathophysiology

Section 04

Risk Factors

Section 05

Diagnosis & Testing

Clinical evaluation by a qualified healthcare professional

Confirmation using ICD-10 criteria (B55.0)

Section 09

Lifestyle & Prevention

Prognosis

Prognosis varies by severity, comorbidities, and access to appropriate care. Discuss expected outcomes with a clinician.

Section 10

Frequently Asked Questions

What is Visceral Leishmaniasis?

What is the ICD-10 code for Visceral Leishmaniasis?

The ICD-10 code is B55.0.

Sources & References

• CDC (Centers for Disease Control) — Epidemiology and clinical guidelines for Visceral Leishmaniasis
• NIH — National Institutes of Health — Clinical research and disease information
• UpToDate Clinical Decision Support — Evidence-based treatment protocols
• PubMed / MEDLINE — View peer-reviewed studies

Last reviewed by MedCentralHub Medical Review Board · MedCentralHub Editorial Policy

Medical Disclaimer

The information on this page is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions about a medical condition.